Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Li, Li ^a   Nadanaciva, Sashi ^a   Berger, Zdenek ^a   Shen, Wei ^a   Paumier, Katrina ^a   Schwartz, Joel ^a   Mou, Kewa ^a   Loos, Paula ^a   Milici, Anthony J ^a   Dunlop, John ^a   Hirst, Warren D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-SYNUCLEIN; ANIMALS; BIOLOGICAL TRANSPORT; CELL RESPIRATION; CEREBRAL CORTEX; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MUTATION; NEURITES; NEURONS; PHENOTYPE; SIROLIMUS;

EID: 84893521264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085815     Document Type: Article

References (78)

1. Samii A, Nutt JG, Ransom BR (2004) Parkinson's disease. Lancet 363: 1783-1793. doi:10.1016/S0140-6736(04)16305-8. PubMed: 15172778. (Pubitemid 38698383)
2. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. doi:10.1126/science. 276.5321.2045. PubMed: 9197268.
3. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608. doi:10.1038/33416. PubMed: 9560156. (Pubitemid 28207717)
4. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW et al. (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10: 119-127. doi:10.1006/nbdi. 2002.0507. PubMed: 12127150.
5. Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R et al. (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99: 14524-14529. doi:10.1073/pnas. 172514599. PubMed: 12376616.
6. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840. doi:10.1038/42166. PubMed: 9278044.
7. Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson's syndromes: a critical review. Curr Opin Genet Dev 19: 254-265. doi:10.1016/j.gde.2009.03.008. PubMed: 19419854.
8. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 8: e1002548. PubMed: 22438815.
9. Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 10: 1015-1025. doi:10.1016/S1474-4422(11)70213-7. PubMed: 22014436.
10. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97: 571-576. doi:10.1073/pnas.97.2.571. PubMed: 10639120. (Pubitemid 30070350)
11. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM et al. (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274: 9843-9846. doi:10.1074/jbc. 274.14.9843. PubMed: 10092675.
12. Li J, Uversky VN, Fink AL (2001) Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40: 11604-11613. doi:10.1021/bi010616g. PubMed: 11560511. (Pubitemid 32911305)
13. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ et al. (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34: 521-533. doi:10.1016/S0896-6273(02)00682- 7. PubMed: 12062037. (Pubitemid 34628750)
14. Schon EA, Przedborski S (2011) Mitochondria: the next (neurode)generation. Neuron 70: 1033-1053. doi:10.1016/j.neuron. 2011.06.003. PubMed: 21689593.
15. Sheng ZH, Cai Q (2012) Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13: 77-93. doi:10.1038/nrg3141. PubMed: 22218207.
16. Li WW, Yang R, Guo JC, Ren HM, Zha XL et al. (2007) Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18: 1543-1546. doi:10.1097/WNR.0b013e3282f03db4. PubMed: 17885598. (Pubitemid 47476380)
17. Shavali S, Brown-Borg HM, Ebadi M, Porter J (2008) Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci Lett 439: 125-128. doi:10.1016/j.neulet. 2008.05.005. PubMed: 18514418.
18. Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486: 235-239. doi:10.1016/j.neulet.2010.09.061. PubMed: 20887775.
19. Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol 41: 2015-2024. doi:10.1016/j.biocel.2009.05.008. PubMed: 19460457.
20. Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P et al. (2011) Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 286: 10814-10824. doi:10.1074/jbc.M110.132514. PubMed: 21252228.
21. Xie W, Chung KK (2012) Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. J Neurochem 122: 404-414. doi:10.1111/j.1471-4159.2012.07769.x. PubMed: 22537068.
22. Banker G, Goslin K (1998) Culturing nerve cells. Cambridge, MA: MIT Press.
23. Banker GA, Cowan WM (1979) Further observation on hippocampal neurons in dispersed cell culture. J Comp Neurol 187: 469-493. doi:10.1002/cne.901870302. PubMed: 385643. (Pubitemid 10220195)
24. Chang DT, Honick AS, Reynolds IJ (2006) Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci 26: 7035-7045. doi:10.1523/JNEUROSCI.1012-06.2006. PubMed: 16807333. (Pubitemid 44309871)
25. 2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 136: 163-174. doi:10.1016/j.cell.2008.11.046. PubMed: 19135897.
26. Chen Y, Sheng ZH (2013) Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport. J Cell Biol 202: 351-364. doi:10.1083/jcb.201302040. PubMed: 23857772.
27. Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D et al. (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284: 13843-13855. doi:10.1074/jbc.M808515200. PubMed: 19279012.
28. Chang KT, Niescier RF, Min KT (2011) Mitochondrial matrix Ca2+ as an intrinsic signal regulating mitochondrial motility in axons. Proc Natl Acad Sci U S A 108: 15456-15461. doi:10.1073/pnas.1106862108. PubMed: 21876166.
29. Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803. doi:10.1083/jcb.200809125. PubMed: 19029340.
30. Chazotte B (2011) Labeling mitochondria with TMRM or TMRE. Cold Spring Harb Protoc 2011:895-897.
31. MacAskill AF, Kittler JT (2010) Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20: 102-112. doi:10.1016/j.tcb. 2009.11.002. PubMed: 20006503.
32. Kang JS, Tian JH, Pan PY, Zald P, Li C et al. (2008) Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 132: 137-148. doi:10.1016/j.cell.2007.11.024. PubMed: 18191227.
33. Brickley K, Stephenson FA (2011) Trafficking kinesin protein (TRAK)-mediated transport of mitochondria in axons of hippocampal neurons. J Biol Chem 286: 18079-18092. doi:10.1074/jbc.M111.236018. PubMed: 21454691.
34. Ligon LA, Steward O (2000) Movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J Comp Neurol 427: 340-350. doi:10.1002/1096-9861(20001120)427:3. PubMed: 11054697.
35. MacAskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J et al. (2009) Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 61: 541-555. PubMed: 19249275.
36. Cai Q, Gerwin C, Sheng ZH (2005) Syntabulin-mediated anterograde transport of mitochondria along neuronal processes. J Cell Biol 170: 959-969. doi:10.1083/jcb.200506042. PubMed: 16157705. (Pubitemid 41306295)
37. Wang X, Schwarz TL (2009) Imaging axonal transport of mitochondria. Methods Enzymol 457: 319-333. PubMed: 19426876.
38. Atkin TA, MacAskill AF, Brandon NJ, Kittler JT (2011) Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry 16: 122-124. doi:10.1038/mp.2010.110. PubMed: 21079610.
39. Tang Y, Scott DA, Das U, Edland SD, Radomski K et al. (2012) Early and selective impairments in axonal transport kinectics of synaptic cargoes induced by soluble amyloid β-protein oligomers. Traffic 13: 681-693. doi:10.1111/j.1600-0854.2012.01340.x. PubMed: 22309053.
40. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175. PubMed: 18188003.
41. Wiedenmann B, Franke WW (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41: 1017-1028. doi:10.1016/S0092-8674(85)80082-9. PubMed: 3924408. (Pubitemid 15243405)
42. Nakata T, Terada S, Hirokawa N (1998) Visualization of the dynamics of synaptic vesicle and plasma membrane proteins in living axons. J Cell Biol 140: 659-674. doi:10.1083/jcb.140.3.659. PubMed: 9456325. (Pubitemid 28134068)
43. Valtorta F, Tarelli FT, Campanati L, Villa A, Greengard P (1989) Synaptophysin and synapsin I as tools for the study of the exo-endocytotic cycle. Cell Biol Int Rep 13: 1023-1038. doi:10.1016/0309-1651(89)90017-9. PubMed: 2517595. (Pubitemid 20058386)
44. Yue Z (2007) Regulation of neuronal autophagy in axon: implication of autophagy in axonal function and dysfunction/degeneration. Autophagy 3: 139-141. PubMed: 17204855.
45. Lee S, Sato Y, Nixon RA (2011) Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J Neurosci 31: 7817-7830. doi:10.1523/JNEUROSCI.6412-10.2011. PubMed: 21613495.
46. Butler EK, Voigt A, Lutz AK, Toegel JP, Gerhardt E et al. (2012) The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity. PLOS Genet 8: e1002488.
47. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM et al. (2011) Direct membrane association drives mitochondrial fission by the Parkinson Disease-associated protein α-synuclein. J Biol Chem 286: 20710-20726. doi:10.1074/jbc.M110.213538. PubMed: 21489994.
48. Gui YX, Wang XY, Kang WY, Zhang YJ, Zhang Y et al. (2012) Extracellular signal-regulated kinase is invovled in alpha-synulcein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1. Neurobiol Aging 33: 2841-2854. doi:10.1016/j.neurobiolaging. 2012.02.001. PubMed: 22445325.
49. Pendergrass W, Wolf N, Poot M (2004) Efficacy of MitoTracker Green and CMSrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry A 61: 162-169. PubMed: 15382028. (Pubitemid 39362290)
50. Kim-Han JS, Antenor-Dorsey JA, O'Malley KL (2011) The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. J Neurosci 31: 7212-7221. doi:10.1523/JNEUROSCI. 0711-11.2011. PubMed: 21562285.
51. Buckman JF, Hernández H, Kress GJ, Votyakova TV, Pal S et al. (2001) MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants. J Neurosci Methods 104: 165-176. doi:10.1016/S0165-0270(00)00340-X. PubMed: 11164242. (Pubitemid 32042519)
52. Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435: 297-312. doi:10.1042/BJ20110162. PubMed: 21726199.
53. Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14: 70-77. doi:10.1016/j.tcb.2003.12.002. PubMed: 15102438.
54. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305: 1292-1295. doi:10.1126/science. 1101738. PubMed: 15333840.
55. Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE et al. (2010) alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 190: 1023-1037. doi:10.1083/jcb. 201003122. PubMed: 20855506.
56. Bové J, Martínez-Vicente M, Vila M (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 12: 437-452. doi:10.1038/nrn3068. PubMed: 21772323.
57. Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 20: 4515-4529. doi:10.1093/hmg/ddr381. PubMed: 21873260.
58. Chen H, Chan DC (2009) Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet 18: R169-R176. doi:10.1093/hmg/ddp326. PubMed: 19808793.
59. Orr AL, Li S, Wang CE, Li H, Wang J et al. (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28: 2783-2792. doi:10.1523/JNEUROSCI. 0106-08.2008. PubMed: 18337408.
60. Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11: 709-730. doi:10.1038/nrd3802. PubMed: 22935804.
61. Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 805-811. doi:10.1038/nn.2575. PubMed: 20581817.
62. Boland B, Kumar A, Lee S, Platt FM, Wegiel J et al. (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28: 6926-6937. doi:10.1523/ JNEUROSCI.0800-08.2008. PubMed: 18596167.
63. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN et al. (2008) A method to measure cardiac autophagic flux in vivo. Autophagy 4: 322-329. PubMed: 18216495. (Pubitemid 351458093)
64. Crews L, Spencer B, Desplats P, Patrick C, Paulino A et al. (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLOS ONE 5: e9313. doi:10.1371/journal.pone.0009313. PubMed: 20174468.
65. Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S et al. (2010) Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet 19: 2144-2153. doi:10.1093/hmg/ ddq093. PubMed: 20190273.
66. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H et al. (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65: 3336-3346. PubMed: 15833867. (Pubitemid 40524618)
67. Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S et al. (2005) The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47: 379-393. doi:10.1016/j.neuron. 2005.06.027. PubMed: 16055062.
68. Liu S, Sawada T, Lee S, Yu W, Silverio G et al. (2012) Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet 8: e1002537. PubMed: 22396657.
69. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL et al. (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147: 893-906. doi:10.1016/j.cell. 2011.10.018. PubMed: 22078885.
70. Yi M, Weaver D, Hajnóczky G (2004) Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 167: 661-672. doi:10.1083/jcb.200406038. PubMed: 15545319. (Pubitemid 39565147)
71. Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N et al. (2006) Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J Neurochem 97: 1071-1077. doi:10.1111/j.1471-4159.2006.03803.x. PubMed: 16606366.
72. Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung CC et al. (2009) alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem 111: 1192-1201. doi:10.1111/j.1471-4159.2009.06411. x. PubMed: 19860837.
73. Pathak D, Sepp KJ, Hollenbeck PJ (2010) Evidence that myosin activity opposes microtubule-based axonal transport of mitochondria. J Neurosci 30: 8984-8992. doi:10.1523/JNEUROSCI.1621-10.2010. PubMed: 20592219.
74. Banerjee K, Sinha M, Pham Cle L, Jana S, Chanda D et al. (2010) Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett 584: 1571-1576. doi:10.1016/j.febslet.2010.03.012. PubMed: 20226185.
75. Mortiboys H, Johansen KK, Aasly JO, Bandmann O (2010) Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 75: 2017-2020. doi:10.1212/WNL.0b013e3181ff9685. PubMed: 21115957.
76. McCoy MK, Cookson MR (2011) DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 7: 531-532. doi:10.4161/auto.7.5. 14684. PubMed: 21317550.
77. Bossy-Wetzel E, Petrilli A, Knott AB (2008) Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 31: 609-616. doi:10.1016/j.tins.2008. 09.004. PubMed: 18951640.
78. Loeb V, Yakunin E, Saada A, Sharon R (2010) The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem 285: 7334-7343. doi:10.1074/jbc.M109.061051. PubMed: 20053987.